Decreased miR-325-5p Contributes to Visceral Hypersensitivity Through Post-transcriptional Upregulation of CCL2 in Rat Dorsal Root Ganglia
- 37 Downloads
Chronic visceral hypersensitivity is an important type of chronic pain with unknown etiology and pathophysiology. Recent studies have shown that epigenetic regulation plays an important role in the development of chronic pain conditions. However, the role of miRNA-325-5p in chronic visceral pain remains unknown. The present study was designed to determine the roles and mechanism of miRNA-325-5p in a rat model of chronic visceral pain. This model was induced by neonatal colonic inflammation (NCI). In adulthood, NCI led to a significant reduction in the expression of miRNA-325-5p in colon-related dorsal root ganglia (DRGs), starting to decrease at the age of 4 weeks and being maintained to 8 weeks. Intrathecal administration of miRNA-325-5p agomir significantly enhanced the colorectal distention (CRD) threshold in a time-dependent manner. NCI also markedly increased the expression of CCL2 (C-C motif chemokine ligand 2) in colon-related DRGs at the mRNA and protein levels relative to age-matched control rats. The expression of CXCL12, IL33, SFRS7, and LGI1 was not significantly altered in NCI rats. CCL2 was co-expressed in NeuN-positive DRG neurons but not in glutamine synthetase-positive glial cells. Furthermore, CCL2 was mainly expressed in isolectin B4-binding- and calcitonin gene-related peptide-positive DRG neurons but in few NF-200-positive cells. More importantly, CCL2 was expressed in miR-325-5p-positive DRG neurons. Intrathecal injection of miRNA-325-5p agomir remarkably reduced the upregulation of CCL2 in NCI rats. Administration of Bindarit, an inhibitor of CCL2, markedly raised the CRD threshold in NCI rats in a dose- and time-dependent manner. These data suggest that NCI suppresses miRNA-325-5p expression and enhances CCL2 expression, thus contributing to visceral hypersensitivity in adult rats.
KeywordsVisceral pain Dorsal root ganglia miRNA-325-5p CCL2 Epigenetic regulation
This work was supported by grants from the National Natural Science Foundation of China (81471137, 31730040, and 81771187) and from the Priority Academic Program Development of Jiangsu Higher Education Institutions of China.
Conflict of interest
No conflicts of interest, financial or otherwise, are declared by the authors.
- 11.Miotla Zarebska J, Chanalaris A, Driscoll C, Burleigh A, Miller RE, Malfait AM, et al. Ccl2 and ccr2 regulate pain-related behaviour and early gene expression in post-traumatic murine osteoarthritis but contribute little to chondropathy. Osteoarthritis Cartilage 2017, 25: 406–412.CrossRefGoogle Scholar
- 20.Su S, Shao J, Zhao Q, Ren X, Cai W, Li L, et al. Mir-30b attenuates neuropathic pain by regulating voltage-gated sodium channel nav1.3 in rats. Front Mol Neurosci 2017, 10: 126.Google Scholar
- 33.Han Q, Liu D, Convertino M, Wang Z, Jiang C, Kim YH, et al. Mirna-711 binds and activates trpa1 extracellularly to evoke acute and chronic pruritus. Neuron 2018, 99: 449–463 e446.Google Scholar